HCA Healthcare (NYSE:HCA) Given New $450.00 Price Target at Robert W. Baird

by · The Markets Daily

HCA Healthcare (NYSE:HCA – Free Report) had its target price raised by Robert W. Baird from $423.00 to $450.00 in a report issued on Thursday,MarketScreener reports. The brokerage currently has a neutral rating on the stock.

Several other research firms have also commented on HCA. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday. Royal Bank Of Canada increased their price objective on HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research note on Monday, October 27th. KeyCorp upped their target price on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Finally, Mizuho increased their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $475.95.

Check Out Our Latest Report on HCA Healthcare

HCA Healthcare Stock Up 0.3%

Shares of HCA Healthcare stock traded up $1.45 on Thursday, reaching $483.80. The company’s stock had a trading volume of 134,733 shares, compared to its average volume of 1,479,971. The stock has a 50-day moving average price of $464.48 and a 200-day moving average price of $412.87. HCA Healthcare has a 52-week low of $289.98 and a 52-week high of $520.00. The company has a market capitalization of $110.40 billion, a P/E ratio of 18.69, a PEG ratio of 1.38 and a beta of 1.36.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at about $1,021,000. Townsquare Capital LLC raised its stake in shares of HCA Healthcare by 24.2% during the 1st quarter. Townsquare Capital LLC now owns 3,117 shares of the company’s stock worth $1,077,000 after buying an additional 607 shares in the last quarter. HighTower Advisors LLC boosted its stake in shares of HCA Healthcare by 690.7% in the first quarter. HighTower Advisors LLC now owns 34,837 shares of the company’s stock valued at $12,038,000 after buying an additional 40,735 shares in the last quarter. Boston Partners boosted its position in shares of HCA Healthcare by 31.5% during the 1st quarter. Boston Partners now owns 164,021 shares of the company’s stock worth $56,677,000 after purchasing an additional 39,250 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC increased its holdings in shares of HCA Healthcare by 80.7% in the 1st quarter. Kovitz Investment Group Partners LLC now owns 25,385 shares of the company’s stock valued at $8,772,000 after purchasing an additional 11,338 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories